BAM
IART icon

Bellevue Asset Management’s Integra LifeSciences IART Stock Holding History

Bellevue Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.76K Buy
+98
New +$1.37K ﹤0.01% 479

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Bellevue Asset Management's IART Position: Q2 2026 in Review

Bellevue Asset Management opened a new position in Integra LifeSciences (IART) in Q2 2026: 98 shares worth $1.76K. The stake represents ﹤0.01% of the portfolio and ranks #479 among its holdings.

212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Bellevue Asset Management held 98 shares of Integra LifeSciences worth $1.76K as of Q2 2026.
  • Integra LifeSciences was a new Bellevue Asset Management position in Q2 2026.
  • Integra LifeSciences made up ﹤0.01% of Bellevue Asset Management's portfolio in Q2 2026, its #479 holding.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Bellevue Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.